Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in South Korea evaluating safinamide mesilate as add-on therapy to levodopa for Parkinson disease with motor fluctuations; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Safinamide Mesilate (safinamide)
• levodopa (levodopa)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-09-23